Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better?: Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

Hyosun Kim’s report "Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A content Analysis of FDA Warning Letters" aims to teach marketers how to avoid breaching current Food and Drug Administration (FDA) guidelines in their online drug promotion. While Kim hopes to mi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Health Policy Manag
Hlavní autor: Doran, Evan
Médium: Artigo
Jazyk:Inglês
Vydáno: Kerman University of Medical Sciences 2016
Témata:
Commentary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4852004/
https://ncbi.nlm.nih.gov/pubmed/27239884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2016.20
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky